Chromosome 11q22.3-q25 LOH in Ovarian Cancer: Association with a More Aggressive Disease Course and Involved Subregions

By Launonen V.   Stenback F.   Puistola U.   Bloigu R.   Huusko P.   Kytola S.   Kauppila A.   Winqvist R.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 299-304

Elsevier

Access to resources Recommend Favorite

Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer

By Glynn Ronan W.   Miller Nicola   Mahon Sarah   Kerin Michael J.  

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 365-369

Spandidos Publications

Access to resources Recommend Favorite

Loss of Heterozygosity in Human Ovarian Cancer on Chromosome 19q

By Bicher A.   Ault K.   Kimmelman A.   Gershenson D.   Reed E.   Liang B.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 36-40

Elsevier

Access to resources Recommend Favorite

A Novel Amplification at 17q21-23 in Ovarian Cancer Cell Lines Detected by Comparative Genomic Hybridization

By Watanabe T.   Imoto I.   Kosugi Y.   Ishiwata I.   Inoue S.   Takayama M.   Sato A.   Inazawa J.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite

Fluorescence in situ hybridization of chromosome 17 polysomy in breast cancer using thin tissue sections causes the loss of CEP17 and HER2 signals

By          

Oncology Reports, Vol. 32, Iss. 5, 2014-01 ,pp. : 1889-1896

Spandidos Publications

Access to resources Recommend Favorite